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Background: The emergence and spread of antibiotic resistance in pathogens have led to a restriction on the use
of antibiotic growth promoters (AGPs) in animal feed in some countries. The potential negative after-effects of a
ban on AGPs could be mitigated by improving animal intestinal health with prebiotic dietary fibers such as
xylo-oligosaccharides (XOS). However, the mechanism(s) by which an antibiotic or prebiotic contributes to the
health and growth of animals are not well understood. Here, we evaluated XOS and virginiamycin (VIRG)-mediated
changes in gut microbiota of broiler chickens using pyrosequencing of the 16S rRNA gene.
Results: There was a significant change in the relative abundance of certain bacteria, but the overall microbial diversity
was not affected by treatment with either XOS or VIRG. Supplementation of HXOS (2 g XOS/kg diet) increased the
proportion of Lactobacillus genus in the cecum, whereas Propionibacterium and Corynebacterium genera were enriched
in the ileum of VIRG (16 mg/kg) treated birds. Furthermore, an increase in the cecal concentrations of acetate and
propionate was observed in HXOS- and VIRG-fed chickens, respectively. These two groups of birds had better feed
conversion efficiencies in comparison with the control group from day 7 to 21. In addition, temporal variations
in the gut microbiota were evident in the chickens of different ages.
Conclusions: Treatments with XOS or VIRG modified the relative abundance but not the presence or absence
of specific microbial genus. The increase in both Lactobacillus spp. and acetate production in the cecum of
HXOS-treated chickens may promote intestinal health.
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Antibiotic growth promoters (AGPs) have been widely
used in poultry production to improve growth perform-
ance, feed efficiency, and overall health [1]. However,
this practice has been discontinued in the European
Union since 2006 due to increasing concern over spread of
antibiotic-resistant genes to human and animal pathogens
[2]. The withdrawal of AGP from poultry feed may increase
bird disease rates, causing a rise in veterinary use of antibi-
otics for therapeutic purpose [3]. Therefore, there is the
need to find effective alternatives to AGPs that improve
chicken health and maintain efficiency of production and
safety of poultry products.* Correspondence: xin.zhao@mcgill.ca
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unless otherwise stated.Although it is still unclear how AGPs enhance animal
performance, it is believed that they mainly act on gut
microbiota [4]. The chicken gastrointestinal microbiota
harbors dynamic and complex bacterial communities with
an important role in metabolic activity and immune devel-
opment [5]. In addition, some gut microbes produce a var-
iety of enzymes that digest complex polysaccharides into
short chain fatty acids (SCFA), mainly acetate, propionate,
and butyrate. SCFA are major end products of bacterial
fermentation of dietary fiber and provide several health ben-
efits to the host including regulation of intestinal inflamma-
tion [6,7]. We have previously shown that supplementation
of certain indigestible but fermentable dietary fibers, such as
mannan oligosaccharides, promoted the growth of bacterial
species with potential health benefits [8]. Accumulating evi-
dence has suggested that xylo-oligosaccharides (XOS) arentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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are not degraded by recognized enteric pathogens such as
Staphylococcus aureus, Clostridium difficile, Salmonella
enterica, and Campylobacter jejuni, probiotic strains such
as Lactobacillus spp. and Bifidobacterium spp. are able to
utilize XOS [11,12]. However, the effect of XOS on the
gut microbiota remains unclear as previous studies have
often relied on in vitro observation [13-15] or microbial
culture methods [16] that fail to provide accurate taxo-
nomic composition and community structure.
Previous analysis of chicken intestinal microbiota using
16S rRNA clone library sequencing method has indicated
that dietary supplementation with sub-therapeutic level of
tylosin [17] or virginiamycin [18] influence the population
of specific bacterial species in the small intestine. A pyrose-
quencing analysis of the 16S V3 region has also revealed a
number of significant changes in the cecal microbiota of
chickens treated with monensin in the presence or absence
of tylosin or virginiamycin [19]. However, their study did
not elucidate how virginiamycin alone could affect micro-
bial communities in the cecum and other gastrointestinal
tract locations. Far less is known about the prebiotic-
mediated changes in the chicken microbiome.
We hypothesized that, in chicken, the mode of action of
virginiamycin or XOS occurs through the gut microbiota.
Therefore, it is necessary to better understand how gastro-
intestinal bacterial communities react to these feed addi-
tives. In this study, we used high-throughput sequencing of
the V1-V3 region of 16S rRNA gene to assess the ileal and
cecal microbiota in male broiler chickens fed either a com-
mercial diet free of antibiotics and prebiotics (CTL), the
same basal diet supplemented with a sub-therapeutic level
(16.5 g/ton diet) of virginiamycin (VIRG), or the basal diet
supplemented with 1 g/kg (LXOS) or 2 g/kg (HXOS) of
XOS. Ileal and cecal concentrations of lactate and SCFA
were also measured.
Results
Sequence analysis and quality filtering
A total of 2,063,514 pyrosequencing reads were obtained
from 96 ileal and cecal samples. After removing 280,537
low-quality and chimeric sequences, the average number
of reads generated per chicken was 17,570 (±8,459 STD)
from ileal samples and 19,444 (±4,273 STD) from cecal
samples, with the median read length of 402 (±93 STD)
bases in all samples. In total, 6,544 distinct operational
taxonomic units (OTUs) at the 97% identity level were ob-
tained from all samples. After rare OTUs (<0.005% of total
OTUs) were removed, a total of 3,248 OTUs remained for
downstream analyses.
Effects of dietary treatments on the ileal microbiota
To assess the within-community (α) diversity, the number
of observed OTUs (at the 97% level) and phylogeneticdiversity (PD) were calculated. None of the dietary
treatments had a significant effect on the α-diversity
indices of the ileal bacterial community (P > 0.05; Figure 1A,
B and Additional file 1: Table S1). Rarefaction curves for the
observed OTUs (Figure 1A) and PD values (Figure 1B)
approach a plateau, indicating that sequencing depth was
sufficient for the coverage of all OTUs present in ileal sam-
ples. Although the number of observed OTUs and the PD
values were higher in chickens fed HXOS, these differences
did not reach a statistical significance (P > 0.05; Additional
file 1: Table S1). PD values differed most between the HXOS
and control group (P = 0.06). To determine similarities
between pairs of microbial communities (β-diversity), a
principal component analysis (PCoA) was performed
using unweighted UniFrac distance matrices. Because
of high inter-individual variation, no distinguishable
clustering of the samples was evident based on the
dietary treatments (Analysis of similarities (ANOSIM):
R = 0.09, P = 0.006; Figure 1C). These results demon-
strated that chickens shared a core set of microbiota in
the ileum regardless of dietary supplementation.
OTUs were taxonomically assigned with the Ribosomal
Database Project (RDP) classifier at 80% confidence
threshold. The relative abundance of OTUs was ana-
lyzed at different ranking levels from phylum to genus.
At the phylum level, ileal microbiota was mainly composed
of Firmicutes (>85%) followed by Proteobacteria, Actino-
bacteria, and Bacteroidetes (Additional file 1: Figure S1).
We used the linear discriminant analysis (LDA) effect size
(LEfSe) method and identified five taxonomic biomarkers
(LDA >2) in the ileal microbial community of VIRG-treated
birds (Figure 1D). The relative abundance of two genera,
Propionibacterium (Figure 1E) and Corynebacterium
(Figure 1F) in Actinobacteria phylum was significantly
(LDA >2) higher in the VIRG group compared with
other dietary groups.
Effects of dietary treatments on the cecal microbiota
Rarefaction curves of 9,000 subsampled reads in the
cecum showed comparable numbers of OTUs (at the
97% identity level) for each dietary treatment (Figure 2A
and Additional file 1: Table S1). Similarly, there was no
apparent difference (P > 0.05) in rarefaction curves for
the PD values (Figure 2B and Additional file 1: Table S1).
The microbial community structure between dietary treat-
ments (β-diversity) was compared using PCoA of the
unweighted UniFrac distances. These PCoA plots showed
that microbial communities from XOS- and VIRG-
supplemented birds did not clearly separate from those
of the non-supplemented birds (R = 0.02, P = 0.78). The
first axis of the PCoA explained 15.3% of the variation in
bacterial diversity while the second axis explained 5.8%
(Figure 2C). More than 99% of the sequences were assigned
to bacterial phyla with the RDP classifier. At the phylum
Figure 1 Treatment effects on ileal microbiota diversity and composition. Rarefaction curves, calculated at the lowest subsample size of
7,000 sequences per sample, show the effects of sequencing efforts on the observed number of OTUs at 97% sequence similarity (A) and
phylogenetic diversity (whole tree) (B). Data are calculated at 3% distance. Error bars show standard deviation for each category. Principal
component analysis (PCoA) of unweighted UniFrac distances from 24 ileal samples shows no difference in the community phylotype structure
among treatments (C). Linear discriminant analysis (LDA) effect size (LEfSe) was used to identify specific phylotypes that significantly associated
with treatments. LDA more than 2 reflects significant difference between groups. LEfSe analysis provided the list of phylotypes that are
differential among dietary supplementations with statistical and biological significance (D). The histograms indicated the increased relative
abundance of the genera Propionibacterium (E) and Corynebacterium (F) in the ileal microbiota of chickens fed VIRG diet compared with other
treatments. Each bar represents the relative abundance of the taxa in a sample at the age of 15 (red line), 25 (green line), and 35 days (blue line).
The mean and median relative abundance are indicated with solid and dashed lines, respectively. CTL: control diet without any antibiotic or
prebiotic; VIRG: control diet supplemented with 16.5 mg virginiamycin; LXOS: control diet supplemented with 1 g/kg xylo-oligosaccharides; HXOS:
control diet supplemented with 2 g/kg xylo-oligosaccharides.
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(>80%), followed by Proteobacteria and Bacteroidetes
(Additional file 1: Figure S1). LEfSe detected a marked
increase (LDA score >4) in the relative abundance ofthe Lactobacillus genus in chickens fed HXOS compared
to other treatment groups (Figure 2D). Figure 2E shows
the histogram of the relative abundance of Lactobacillus
in each treatment at different time points.
Figure 2 Treatment effects on diversity and composition of cecal microbiota. Alpha diversity indices were calculated on rarefied samples at
the lowest subsample size of 9,000 sequences per sample. There was no significant (nonparametric t-test, P > 0.05) effects of prebiotic or
antibiotic on the observed number of OTUs (A) and phylogenetic diversity (whole tree) (B). Error bars show standard deviation for each category.
Unweighted UniFrac PCoA plot shows no separation of bacterial communities between dietary groups (C). Key phylotypes of cecal microbiota
responding to dietary treatments were identified using LEfSe algorithm (D). The histogram shows the increased abundance of the genus
Lactobacillus in the cecal microbiota of chickens fed HXOS diet compared with other treatments (E). Each bar represents the relative abundance
of the taxa in a sample at the age of 15 (red line), 25 (green line), and 35 days (blue line). The mean and median relative abundance are
indicated with solid and dashed lines, respectively. CTL: control diet without any antibiotic or prebiotic; VIRG: control diet supplemented with
16.5 g/ton virginiamycin; LXOS: control diet supplemented with 1 g/kg xylo-oligosaccharides; HXOS: control diet supplemented with
2 g/kg xylo-oligosaccharides.
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The number of observed OTUs and PD values were
higher (P < 0.001) in the cecal samples than those in cor-
responding ileal samples (Figure 3A,B), indicating that
the cecal microbiota was more diversified than the ileal
microbiota. The PCoA of OTUs from the ileum and
cecum (Figure 3C) also demonstrated that the bacterial
community structure differed significantly according to
sampling site (R= 0.94, P= 0.001). In addition, the phylogen-
etic composition of the microbiota was noticeably different
between ileum and cecum samples. LEfSe results showed
that 46 bacterial clades at all taxonomic levels were differen-
tially abundant (LDA score >2.0) between the ileal and cecal
microbiota (Figure 3D). Lactobacillaceae and Clostridiaceae
were the dominant families in the ileum while the
cecum was inhabited mostly by the Lachnospiraceae
and Ruminococcaceae families (Additional file 1: Figure S1).
The most dominant genera in the cecum were Ruminococcusand Oscillospira accounting for greater than 35% of all ob-
served sequences.
Temporal changes in the ileal and the cecal microbiota
To determine whether the age of the birds affected the
gut microbiota, the ileal and cecal microbiota of chick-
ens at different ages, 15, 25, and 35 days old, in each
treatment group were compared. Rarefaction plots indi-
cated no significant (P > 0.05) changes in α-diversity
metrics of the ileal samples at three different time points
(Figure 4A,B and Additional file 1: Table S2). Unweighted
Unifrac PCoA revealed the statistical significant effect of
age on the ileal samples (P = 0.01) but the R value was
relatively small (R = 0.1) and therefore the difference was
probably not biologically significant (Figure 4C). In the
cecum, a marked increase (P < 0.01) in observed OTUs
and the PD values occurred on day 35 compared with
cecal samples from day 15 and 25 (Figure 4D,E and
Figure 3 Differences between ileal and cecal microbiota of broiler chickens. Rarefaction curves for ileal and cecal bacteria, for the observed
OTUs (A) and phylogenetic diversity (B) indices. Significant differences were seen between the alpha diversity indices of ileal samples and
samples taken from cecum (nonparametric t-test, P < 0.01). PCoA analysis of OTUs (C) indicates that the bacterial profile differed strongly
according to sampling site (R = 094, P = 0.001). Taxa significantly associated with ileal communities (green) versus cecal communities (red), shown
in circular cladogram based on the Ribosomal Database Project (RDP) bacterial taxonomy (D). The cutoff value of linear discriminant analysis
(LDA) was 2.0 or higher. Biomarker taxa are heighted by colored circles and shaded areas. Each circle’s diameter is relative to abundance of taxa
in community.
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UniFrac distances indicated a clear separation between
samples from day 35 and samples taken at days 15 and
25 (R = 0.42, P < 0.01; Figure 4F). Bacteria that weredifferentially abundant between sampling times in the ileum
and cecum were detected using LEfSe (Figure 4G,H). For
example, in the ileum, the order Burkholderiales and the
candidate genus SMB53 of Clostridiaceae were the most
Figure 4 Ileal and cecal microbiota of broiler chickens at different ages. Observed OTUs (A) and phylogenetic diversity (B) rarefactions of
ileal samples collected on days 15, 25, and 35. Unweighted Unifrac PCoA shows a statistically, but not biologically, significant effect of age on the
ileal microbiota (R = 0.1, P = 0.01) (C). Alpha rarefaction analysis of cecal samples (D, E) shows that observed OTUs and phylogenetic diversity both
increased on day 35 compared with those samples collected on day 15 and 25 (P < 0.01). A separate clustering of cecal microbiota was observed
on day 35 (R = 0.42, P < 0.01) (F). The LEfSe provided the list differentially abundant taxa between ages in the ileum (G) and cecum (H). The cutoff
value of linear discriminant analysis (LDA) was 2.0 or higher.
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(Figure 4G). The most differentially overrepresented taxa
in the cecum at 15, 25, and 35 days of age were the genus
Enterococcus, family Rikenellaceae and genus Oscillospira,
respectively (Figure 4H).
SCFA in the ileum and cecum
To further identify whether the observed microbial changes
due to dietary treatment also affected the gut function, SCFA
and lactate concentrations were measured. In the ileum, the
acetate concentration ranged from 6.2 to 7.1 μmol/g digesta
and was not affected by dietary treatments, while lactate,
propionate and butyrate were not detected (data not shown).
The cecal propionate concentration in the VIRG group was
significantly higher (P < 0.05) than LXOS and HXOS groups
on day 15 (Figure 5A) and also significantly higher than the
control, LXOS and HXOS groups on day 35 (Figure 5C).
The cecal acetate concentration was significantly higher in
the HXOS group than in the VIRG group on days 25
and 35 (P < 0.05; Figure 5B,C) and the LXOS group on
day 25 (P < 0.01; Figure 5B). Correlation analyses showed
that the relative abundance of the Lactobacillus genus in
the cecum was positively correlated with cecal acetate pro-
duction (R = 0.57, P < 0.05), whereas ileal Propionibacterium
relative abundance was positively correlated with cecal
propionate concentrations (R = 0.51, P < 0.05).Figure 5 SCFA and lactate concentrations in the cecum. Lactate, aceta
cecal samples collected on 15 (A), 25 (B), and 35 (C) days of age. Significan
Scheffe’s multiple comparison test by ANOVA. CTL: control diet without any
virginiamycin; LXOS: control diet supplemented with 1 g xylo-oligosaccharideGrowth performance
Results for production traits of broilers through the ex-
perimental period are shown in Table 1. The average
body weight of chickens did not differ among treat-
ments. The feed conversion ratio (FCR) in broilers fed
VIRG and HXOS diets was lower (P < 0.05) than those
fed CTL or LXOS between days 7 and 21. No difference
was observed in FCR during the first week and last
15 days of experiment. The mortality rate of chickens
was not affected by dietary treatments and was lower
than 7% in all groups.
Discussion
High-throughput sequencing of 16S rRNA gene ampli-
cons has been used more recently to identify functional
diversity [20] or variability [21] of the microbiome in the
gut of broiler chickens. However, on the subject of diet-
ary supplementation with XOS or VIRG, previous stud-
ies have used either low-resolution bacterial detection
techniques [16-18] or considered an antibiotic mixture,
rather than VIRG alone [19]. In the present study, we
used high-throughput sequencing of the V1-V3 region of
the 16S rRNA gene to monitor the ileal and cecal micro-
biota of a large number of individual chickens fed either
a sub-therapeutic level of VIRG or one of two levels of
XOS over a 5-week production cycle. VIRG is one of thete, propionate, and butyrate concentrations (μmol/g content) of 24
t differences (*P < 0.05 and **P < 0.01) were detected using the
antibiotic or prebiotic; VIRG: control diet supplemented with 16.5 g/ton
s/kg; HXOS: control diet supplemented with 2 g xylo-oligosaccharides/kg.
Table 1 Growth performance of broilers in different
treatment groups
Parameter Treatments SEM
CTL VIRG LXOS HXOS
Body weight (g)
Day 0 38.9 38.5 40.0 39.6 4.2
Day 7 261.5 254.4 269.7 259.0 18.3
Day 21 733.6 753.0 728.2 741.5 29.1
Day 35 1,892.0 1,909.0 1,891.2 1,914.7 26.7
Feed conversion ratio
Days 0 to 7 0.95 0.97 1.00 1.02 0.081
Days 7 to 21 1.77a 1.61b 1.75a 1.62b 0.044
Days 21 to 35 2.14 2.09 2.17 2.13 0.078
Survival (%) 93.3 93.3 96.6 93.3 1.0
CTL: control diet without any antibiotic or prebiotic; VIRG: control diet
supplemented with 16.5 g/ton virginiamycin; LXOS: control diet supplemented
with 1 g/kg xylo-oligosaccharides; HXOS: control diet supplemented with 2 g/kg
xylo-oligosaccharides; SEM: standard error of the mean. Each mean represents six
replicate cages with five broilers per cage. a,bMeans in the same row with different
superscripts differ (P < 0.05).
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industry for disease prevention and growth promotion.
Our results indicate that VIRG and XOS differentially
modified the proportion of specific OTUs and these
changes were associated with cecal acetate and propion-
ate production.
Based on the phylogenetic diversity of bacterial com-
munities and number of observed OTUs, we concluded
that the VIRG inclusion (16.5 g/ton) did not change the
chicken ileal and cecal bacterial community member-
ship. Similar results have been previously reported in
chicken [19,22] and swine gut microbiota following
treatments with in-feed antibiotics [23-25]. However,
VIRG treatment significantly altered relative abundance
of certain taxa in the ileum whereas no effect was ob-
served on the cecal microbial composition. This obser-
vation is in accordance with the study of Dumonceaux
et al. [18] who reported that virginiamycin addition
(20 g/ton) altered the chicken gut microbiota most sig-
nificantly in the upper intestinal tract. In contrast, Dan-
zeisen et al. [19] described a number of changes in the
proportion of taxa including a reduction in lactobacilli
and an increase in Escherichia coli in the cecal contents of
chicken exposed to a mixture of monensin (110 g/ton)
with virginiamycin (15 g/ton) or tylosin (20 g/ton). This
discrepancy is likely due to the higher dose of antibiotic
used in their study. Interestingly, lactobacilli was not
identified as a biomarker of VIRG treatment in our
study, although it is generally considered to be reduced
with antibiotics [17,19,26]. The relatively low levels of
antibiotics used in Canadian poultry industry and in
the present study may be responsible for the lack ofsignificant changes in the gut bacterial community
membership or the cecal microbial composition in the
current study.
We identified two genera of bacteria as being linked
to VIRG treatment, namely Corynebacterium and
Propionibacterium. Dumonceaux et al. [18] also ob-
served an increase in Corynebacterium glutamicum in
the proximal intestinal of virginiamycin-treated chickens,
using quantitative PCR method. Under anaerobic condi-
tions, C. glutamicum catabolizes different carbohydrates
and produces organic acids such as lactate and succinate
[27]. The genus Propionibacterium is a gram-positive bac-
terium with a unique ability to produce propionate. In our
study, the propionate concentration was lower than the
limit of detection in the ileum. However, a marked in-
crease in cecal propionate concentration was observed as
a result of the VIRG treatment and was positively cor-
related with the change in the relative abundance of
Propionibacterium in the ileum. The immunomodulatory
effects of selected strains of Propionibacterium such as
Propionibacterium freudenreichii and Propionibacterium
acidipropionici have been established in humans and ani-
mals [28-31]. Propionibacterium species are also able to
bind to aflatoxin B1 and reduce its intestinal absorption in
chickens [32]. Aflatoxin B1 is a major food contaminant
in poultry production that depresses growth performance.
At this point, it is unclear whether the improved feed
efficiency in VIRG-fed chickens is related to the in-
creased relative abundance of Corynebacterium and
Propionibacterium or not. We hypothesize that these
genera may contribute to reported growth promoting
functions of antibiotic.
While XOS are not digestible by gastrointestinal di-
gestive enzymes, they can be fermented by the gut
microbiota, producing SCFA and lactate [33]. Previous
studies on humans [34], rats [35,36], and chickens
[16,37] have analyzed cultivable members of the fecal
and cecal microbiota and found that XOS is effective in
promoting intestinal health by encouraging the growth
of beneficial bacterial species. Our results demonstrate
that the cecal microbiota of HXOS-fed chickens con-
tained significantly higher proportions of the genus
Lactobacillus than the other dietary treatments. Several
strains of Lactobacillus have been identified as func-
tional probiotics with associated anti-inflammatory and
antimicrobial activities. In vitro fermentation of XOS by
Lactobacillus brevis and Lactobacillus fermentum has
been previously reported [11]. Lactate produced by
Lactobacillus species, is rarely accumulated and is
mostly converted to butyrate and acetate as shown by
in vitro studies [38,39]. This was substantiated in the
current study by the increased production of acetate
after HXOS supplementation in comparison with the
VIRG and LXOS groups.
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obtained per sample in this study was higher than previ-
ously published studies of the chicken gut microbiota
[19-21]. This has enabled us to provide a more com-
prehensive view about the ileal and cecal microbiota
composition and structure. The ileal microbiota was
mainly composed of Firmicutes (>85%), and within this
phylum, the majority belonged to the Lactobacillus genus,
a finding that is consistent with previous 16S rRNA gene-
based studies [40,41]. In addition to Lactobacillus, an un-
known genus in the Clostridiaceae family was reported to
be dominant in the ileum [41]. This was identified as the
genus Candidatus Arthromitus in our study. In cecal sam-
ples, most of the OTUs were classified as, Oscillospira,
Ruminococcus and unknown genera of the Lachnospiraceae
and Clostridiaceae families, which was in accordance with
the earlier pyrosequencing-based studies [19,42].
Furthermore, we found that cecal bacterial diversity
increased over time, similar to what has been previously
observed in chicken [19,22,43] and wild bird species
[44]. In addition, the relative abundance of certain
bacterial families or genera was altered over time in the
ileum and cecum of the chickens. For example, the
relative abundance of the genus Enterococcus declined
whereas Faecalibacterium and Clostridium increased
in the cecum with increasing age. It was also noted
that Enterobacteriaceae, a family that comprises many
known pathogens such as Salmonella, Shigella, and E. coli,
was more abundant in the ileum and cecum of the young
birds. Similar results were obtained by Wise et al. [45]
in a quantitative PCR-based study using group-specific
16S rDNA primers. They reported that members of
Enterobacteriaceae are the most abundant in the cecum
at day 7 but being replaced by obligate anaerobe se-
quences by days 14 and 21. The ileal bacterial community
appeared to be more stable than the cecum, a finding that
was similar to the observation of Lu et al. [46]. Bird age,
as evident from this study and others [19,22], had a
higher impact on gut microbiota as compared to diet-
ary treatments.
Conclusions
Taken together, this study indicates that dietary pre-
biotic or sub-therapeutic antibiotic supplementation
modulated the relative abundance of specific bacteria
without changing the overall microbial structure. We
showed that bacterial community clustering was mainly
due to the sample location and the age of the birds ra-
ther than dietary supplementation. Increased popula-
tion levels of lactate-producing bacteria and elevated
cecal acetate concentrations in chickens fed HXOS
might be an intestinal health-promoting attribute and
may contribute to improved feed efficiency during the
growth period.Methods
Birds, diet, and experimental design
One hundred and twenty male 1-day-old broiler chick-
ens (Ross × Ross) were obtained from a local commercial
hatchery and grown over a 35-day experimental period
at the Macdonald Campus Poultry Complex, McGill
University. Birds were randomly assigned to one of four
dietary treatments (six cage replicates; five birds/cage)
which included 1) CTL: a commercial and typical
broiler diet without any supplements, 2) VIRG: diet 1
supplemented with sub-therapeutic levels of virginia-
mycin (16.5 g/ton diet), 3) LXOS: diet 1 + 1 g XOS/kg,
and 4) HXOS: diet 1 + 2 g XOS/kg. The main ingredi-
ents of the diets were corn and soybean meal, formu-
lated according to the NRC requirement (Additional
file 1: Table S3). Chickens had free access to feed and
water. Birds were raised under controlled environmental
conditions with an 18-h lighting cycle and a temperature
of 32°C at day 1 which was gradually reduced and main-
tained at 24°C on day 10. Body weight (BW) and feed in-
take were recorded on a cage-by-cage basis on days 7, 21,
and 35. FCR was calculated as feed intake (kg) divided by
body mass gain (kg). The animal use protocol was accord-
ing to the guidelines of the Canadian Council on Animal
Care and approved by the Animal Ethics Committee of
McGill University (Protocol no. 2012–6073).
Sample collection and DNA extraction
Four birds per treatment were randomly chosen at three
different time points, 15, 25, and 35 days of age, and
euthanized by electrical stunning and carotid artery
bleeding. The ileum (about 2 cm proximal to cecal ton-
sils) and cecum were collected within 5 min of euthan-
asia, immediately placed in cryogenic vials, snap-frozen
in liquid nitrogen, delivered to the laboratory and stored
at −80°C until DNA extraction. Total genomic DNA was
isolated from 220 mg of frozen ileal and cecal contents
using the QIAamp DNA Stool Mini Kit (Qiagen, Toronto,
ON, Canada). The DNA concentration and purity was de-
termined using a NanoDrop 2000 spectrophotometer
(Thermo Scientific, MA, USA).
Pyrosequencing
The normalized concentration (20 ng/μl) of purified
genomic DNA was used as a template to analyze the mi-
crobial communities. The V1-V3 region of the 16S rRNA
gene was amplified using universal eubacterial primers
(27 F: AGRGTTTGATCMTGGCTCAG and 519R: GT
NTTACNGCGGCKGCTG) [47]. Unique 8 nucleotide
sample-specific barcodes and Roche 454 A-adapters
(Roche, Basel, Switzerland) were fused to the 5′ end of
the forward primer while the B-adapters were added to
the 5′ end of the reverse primer. PCR reactions were
performed by initial denaturation at 94°C for 3 min and
Pourabedin et al. Microbiome  (2015) 3:15 Page 10 of 12then 28 cycles of 94°C for 30 s, 53°C for 40 s and 72°C for
1 min, followed by a final elongation step at 72°C for
5 min. PCR products were purified using the MinElute kit
(Qiagen, Toronto, ON, Canada). Amplicon pyrosequenc-
ing was performed at the MR DNA sequencing center
(Shallowater, TX, USA) using 454 GS FLX technology.
Data processing
Sequence reads were analyzed by the quantitative insights
into microbial ecology (QIIME) v.1.8.0 software package
[48]. Briefly, sequences were demultiplexed and assigned
to individual samples according to the specific barcode of
each sample. Barcodes and primers were trimmed, where
maximum two base differences in barcodes and no primer
mismatches were permitted. Sequences were excluded if
they were not meeting the default QIIME quality criteria.
Sequences with an average quality score less than 25 in a
sliding window of 50 nucleotides were also discarded. The
sequence data were denoised using the denoise_wrapper.py
command [49] within QIIME. The chimeras were identi-
fied using the UCHIME method [50] against the GOLD
database and removed from further analyses.
The remaining quality-filtered reads were clustered de
novo (97% similarity threshold) into OTUs using the
CD-HIT method [51], and the most abundant sequence
was selected as the OTU representative. The sequence
alignment was performed against the Greengenes core
set using the PyNAST method [52]. OTUs were taxo-
nomically categorized using the naïve Bayesian RDP
classifier [53] trained on the Greengenes database with a
minimum confidence score of 0.8. For downstream ana-
lysis, the OTU table was filtered by discarding OTUs
that comprised fewer than 0.005% of all sequences [54].
Cecal SCFA and lactate concentrations
For determination of cecal SCFA and lactate concentra-
tions, 0.5 g of fresh cecal contents were diluted in 1 ml of
10% perchloric acid, homogenized, and centrifuged at
15,000 × g for 10 min at 4°C. The supernatant was filtered
through syringe filters with 25-mm diameter membrane
and stored at −20°C. The samples (20 μl) were injected
into a high performance liquid chromatograph (HPLC)
system equipped with a Varian ProStar AutoSampler
(Hamilton, Reno, NV, USA), a UV detector (210 nm), and
an ion-exclusion Aminex HPX-87H 300 × 7.8 mm column
(Bio-Rad, Hercules, CA, USA). The column was main-
tained at room temperature with 0.013 M sulfuric acid as
the eluent (0.6 ml/min flow rate). Lactate, acetate, propi-
onate, and butyrate in the samples were quantified using
external calibration curves.
Statistical measurements
To compare the microbial community structure, un-
weighted UniFrac distance matrices were computed usingthe OTU table and phylogenetic tree information to serve
as input to plot PCoA using QIIME. ANOSIM with 999
permutations was used to detect statistical significances
between microbial communities in different groups. This
test measures a value of R, normally scaled from 0 to 1,
which is based on the average rank similarity among
groups and replicates within each group [55]. R = 0 indi-
cates that two groups are similar whereas R = 1 shows a
perfect separation between groups. Differentially abundant
taxa were identified using the LEfSe method [56]. The
LEfSe algorithm uses the nonparametric factorial Kruskal-
Wallis test (α = 0.05) to analyze differences between clas-
ses (treatments) and the pairwise Wilcoxon test (α = 0.05)
to check differences among subclasses (time points)
within different classes. To evaluate the α-diversity in
samples, the rarefaction curves of PD and number of ob-
served OTUs were computed using QIIME. To normalize
the sequencing depth, the lowest counts among samples
were randomly subsampled in each library 1,000 times
and average values were used to measure diversity indices.
The differences between the mean values were identified
by analyses of variance (ANOVA) and Scheffe’s multiple
comparison test using SAS v9.1 software. PROC CORR
was used to analyze the Pearson correlation between bac-
terial genera and SCFA concentrations. The differences of
growth performance parameters among treatments were
analyzed by one-way ANOVA, and each cage was consid-
ered as an experimental unit.
Availability of supporting data
The raw sequence data obtained in this study has been
deposited in the Sequence Read Archive (SRA) database
of the National Center for Biotechnology Information
(NCBI) with an access number of SRP044612.
Additional file
Additional file 1: Supplementary data. Table S1. Statistical comparison
of alpha diversities between treatments in the ileal and cecal
microbiota. A nonparametric t-test was run in QIIME to compare the
alpha diversities using the default number of Monte Carlo
permutations (999) and the greatest rarefaction depth. Cells shaded
with light blue (upper right section) shows the P values for the
number of observed species while those shaded with light yellow
(lower left section) shows the P values of phylogenetic diversity
comparison. Table S2. Statistical comparison of alpha diversities
between ages in the ilea and cecal microbiota. A nonparametric two
sample t-test was run in QIIME to compare the alpha diversities using
the default number of Monte Carlo permutations (999) and the
greatest rarefaction depth. Cells shaded with light blue (upper right
section) shows the P values for the number of observed species while
those shaded with light yellow (lower left section) shows the P values
of phylogenetic diversity comparison. Significant P values are bolded.
Table S3. Ingredient composition (g/kg) of experimental diets.
Figure S1. The ileal and cecal microbial composition on days 15, 25, and 35.
The bar charts indicate the relative abundance (%) of bacterial phyla (A) and
the dominant (>0.5% of sequences) bacterial families and genera (B) in the
ileum and cecal microbiota of chickens. Classification is according to the RDP
Pourabedin et al. Microbiome  (2015) 3:15 Page 11 of 12trained on the Greengenes database with a minimum confidence score of
0.8. For each habitant, ileal and cecal contents of 16 birds were collected at
15, 25, and 35 days old.
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